Literature DB >> 3440824

Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness.

S Balzano1, F Sau, L Bartalena, M Ruscazio, A Balestrieri, A Cherchi, E Martino.   

Abstract

A rare case of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with nonthyroidal illness is reported. Serum total thyroxine (TT4) and free T4 (FT4) concentrations were elevated and serum TSH was undetectable as frequently observed also in euthyroid amiodarone-treated patients. At variance with common forms of AIIT, serum total triiodothyronine (TT3) was reduced due to low-T3 syndrome. The laboratory diagnosis was made on the basis of elevated free T3 (FT3) levels. Thus, in patients with severe nonthyroidal illness submitted to chronic amiodarone treatment, thyroid status can only be determined by free hormone measurement, particularly FT3 in the case of thyrotoxicosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440824     DOI: 10.1007/BF03347002

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  Letter: Does T4 toxicosis exist?

Authors:  J G Turner; B E Brownlie; W A Sadler
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

2.  Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay.

Authors:  P B Romelli; F Pennisi; L Vancheri
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

3.  Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; M Lenziardi; L Baschieri; L E Braverman; A Pinchera
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

4.  Hyperthyroidism without triiodothyronine excess: an effect of severe non-thyroidal illness.

Authors:  D Engler; E B Donaldson; J R Stockigt; P Taft
Journal:  J Clin Endocrinol Metab       Date:  1978-01       Impact factor: 5.958

5.  Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.

Authors:  E Martino; M Safran; F Aghini-Lombardi; R Rajatanavin; M Lenziardi; M Fay; A Pacchiarotti; N Aronin; E Macchia; C Haffajee
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

6.  Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.

Authors:  A Burger; D Dinichert; P Nicod; M Jenny; T Lemarchand-Béraud; M B Vallotton
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

7.  Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.

Authors:  L Bartalena; E Martino; A Pacchiarotti; L Grasso; F Aghini-Lombardi; L Buratti; G Bambini; M Breccia; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1987-04       Impact factor: 5.958

8.  Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.

Authors:  S Melmed; K Nademanee; A W Reed; J A Hendrickson; B N Singh; J M Hershman
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

9.  T4 thyrotoxicosis with normal or low serum T3 concentration.

Authors:  A Joasoo
Journal:  Aust N Z J Med       Date:  1975-10

10.  The free triiodothyronine (T3) index.

Authors:  C T Sawin; D Chopra; J Albano; F Azizi
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

View more
  1 in total

1.  2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction.

Authors:  Luigi Bartalena; Fausto Bogazzi; Luca Chiovato; Alicja Hubalewska-Dydejczyk; Thera P Links; Mark Vanderpump
Journal:  Eur Thyroid J       Date:  2018-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.